Global RNA Drugs Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
The global RNA Drugs market size is projected to grow from US$ 7465.3 million in 2023 to US$ 10560 million in 2030; it is expected to grow at a CAGR of 5.1% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “RNA Drugs Industry Forecast” looks at past sales and reviews total world RNA Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected RNA Drugs sales for 2024 through 2030. With RNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Drugs industry.
This Insight Report provides a comprehensive analysis of the global RNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
What is the 10-year outlook for the global RNA Drugs market?
What factors are driving RNA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Drugs market opportunities vary by end market size?
How does RNA Drugs break out type, application?
The global RNA Drugs market size is projected to grow from US$ 7465.3 million in 2023 to US$ 10560 million in 2030; it is expected to grow at a CAGR of 5.1% from 2024 to 2030.
LP Information, Inc. (LPI) ' newest research report, the “RNA Drugs Industry Forecast” looks at past sales and reviews total world RNA Drugs sales in 2023, providing a comprehensive analysis by region and market sector of projected RNA Drugs sales for 2024 through 2030. With RNA Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Drugs industry.
This Insight Report provides a comprehensive analysis of the global RNA Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Drugs.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type
- siRNA
- ASO
- miRNA
- Nucleic Acid Aptamers
- Cancer
- Diabetes
- Tuberculosis
- Cardiovascular Diseases
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Roche
- Sanofi-Aventis
- Abbott Laboratories
- Arrowhead Pharmaceuticals
- Benitec Biopharma
- Calimmune Inc
- Dicerna
- Gradalis
- Quark
- RXi
- Senesco
- Silence Therapeutics
- Silenseed
- Tekmira
- Alnylam Pharmaceuticals
What is the 10-year outlook for the global RNA Drugs market?
What factors are driving RNA Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Drugs market opportunities vary by end market size?
How does RNA Drugs break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for RNA Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for RNA Drugs by Country/Region, 2019, 2023 & 2030
2.2 RNA Drugs Segment by Type
2.2.1 siRNA
2.2.2 ASO
2.2.3 miRNA
2.2.4 Nucleic Acid Aptamers
2.3 RNA Drugs Sales by Type
2.3.1 Global RNA Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global RNA Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global RNA Drugs Sale Price by Type (2019-2024)
2.4 RNA Drugs Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Tuberculosis
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 RNA Drugs Sales by Application
2.5.1 Global RNA Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global RNA Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global RNA Drugs Sale Price by Application (2019-2024)
3 GLOBAL RNA DRUGS BY COMPANY
3.1 Global RNA Drugs Breakdown Data by Company
3.1.1 Global RNA Drugs Annual Sales by Company (2019-2024)
3.1.2 Global RNA Drugs Sales Market Share by Company (2019-2024)
3.2 Global RNA Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global RNA Drugs Revenue by Company (2019-2024)
3.2.2 Global RNA Drugs Revenue Market Share by Company (2019-2024)
3.3 Global RNA Drugs Sale Price by Company
3.4 Key Manufacturers RNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers RNA Drugs Product Location Distribution
3.4.2 Players RNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic RNA Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global RNA Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global RNA Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic RNA Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global RNA Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global RNA Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas RNA Drugs Sales Growth
4.4 APAC RNA Drugs Sales Growth
4.5 Europe RNA Drugs Sales Growth
4.6 Middle East & Africa RNA Drugs Sales Growth
5 AMERICAS
5.1 Americas RNA Drugs Sales by Country
5.1.1 Americas RNA Drugs Sales by Country (2019-2024)
5.1.2 Americas RNA Drugs Revenue by Country (2019-2024)
5.2 Americas RNA Drugs Sales by Type
5.3 Americas RNA Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Drugs Sales by Region
6.1.1 APAC RNA Drugs Sales by Region (2019-2024)
6.1.2 APAC RNA Drugs Revenue by Region (2019-2024)
6.2 APAC RNA Drugs Sales by Type
6.3 APAC RNA Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe RNA Drugs by Country
7.1.1 Europe RNA Drugs Sales by Country (2019-2024)
7.1.2 Europe RNA Drugs Revenue by Country (2019-2024)
7.2 Europe RNA Drugs Sales by Type
7.3 Europe RNA Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA Drugs by Country
8.1.1 Middle East & Africa RNA Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa RNA Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa RNA Drugs Sales by Type
8.3 Middle East & Africa RNA Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RNA Drugs
10.3 Manufacturing Process Analysis of RNA Drugs
10.4 Industry Chain Structure of RNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 RNA Drugs Distributors
11.3 RNA Drugs Customer
12 WORLD FORECAST REVIEW FOR RNA DRUGS BY GEOGRAPHIC REGION
12.1 Global RNA Drugs Market Size Forecast by Region
12.1.1 Global RNA Drugs Forecast by Region (2025-2030)
12.1.2 Global RNA Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global RNA Drugs Forecast by Type
12.7 Global RNA Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer RNA Drugs Product Portfolios and Specifications
13.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche RNA Drugs Product Portfolios and Specifications
13.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Sanofi-Aventis
13.3.1 Sanofi-Aventis Company Information
13.3.2 Sanofi-Aventis RNA Drugs Product Portfolios and Specifications
13.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi-Aventis Main Business Overview
13.3.5 Sanofi-Aventis Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories RNA Drugs Product Portfolios and Specifications
13.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Arrowhead Pharmaceuticals
13.5.1 Arrowhead Pharmaceuticals Company Information
13.5.2 Arrowhead Pharmaceuticals RNA Drugs Product Portfolios and Specifications
13.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Arrowhead Pharmaceuticals Main Business Overview
13.5.5 Arrowhead Pharmaceuticals Latest Developments
13.6 Benitec Biopharma
13.6.1 Benitec Biopharma Company Information
13.6.2 Benitec Biopharma RNA Drugs Product Portfolios and Specifications
13.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Benitec Biopharma Main Business Overview
13.6.5 Benitec Biopharma Latest Developments
13.7 Calimmune Inc
13.7.1 Calimmune Inc Company Information
13.7.2 Calimmune Inc RNA Drugs Product Portfolios and Specifications
13.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Calimmune Inc Main Business Overview
13.7.5 Calimmune Inc Latest Developments
13.8 Dicerna
13.8.1 Dicerna Company Information
13.8.2 Dicerna RNA Drugs Product Portfolios and Specifications
13.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dicerna Main Business Overview
13.8.5 Dicerna Latest Developments
13.9 Gradalis
13.9.1 Gradalis Company Information
13.9.2 Gradalis RNA Drugs Product Portfolios and Specifications
13.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Gradalis Main Business Overview
13.9.5 Gradalis Latest Developments
13.10 Quark
13.10.1 Quark Company Information
13.10.2 Quark RNA Drugs Product Portfolios and Specifications
13.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Quark Main Business Overview
13.10.5 Quark Latest Developments
13.11 RXi
13.11.1 RXi Company Information
13.11.2 RXi RNA Drugs Product Portfolios and Specifications
13.11.3 RXi RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 RXi Main Business Overview
13.11.5 RXi Latest Developments
13.12 Senesco
13.12.1 Senesco Company Information
13.12.2 Senesco RNA Drugs Product Portfolios and Specifications
13.12.3 Senesco RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Senesco Main Business Overview
13.12.5 Senesco Latest Developments
13.13 Silence Therapeutics
13.13.1 Silence Therapeutics Company Information
13.13.2 Silence Therapeutics RNA Drugs Product Portfolios and Specifications
13.13.3 Silence Therapeutics RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Silence Therapeutics Main Business Overview
13.13.5 Silence Therapeutics Latest Developments
13.14 Silenseed
13.14.1 Silenseed Company Information
13.14.2 Silenseed RNA Drugs Product Portfolios and Specifications
13.14.3 Silenseed RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Silenseed Main Business Overview
13.14.5 Silenseed Latest Developments
13.15 Tekmira
13.15.1 Tekmira Company Information
13.15.2 Tekmira RNA Drugs Product Portfolios and Specifications
13.15.3 Tekmira RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Tekmira Main Business Overview
13.15.5 Tekmira Latest Developments
13.16 Alnylam Pharmaceuticals
13.16.1 Alnylam Pharmaceuticals Company Information
13.16.2 Alnylam Pharmaceuticals RNA Drugs Product Portfolios and Specifications
13.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Alnylam Pharmaceuticals Main Business Overview
13.16.5 Alnylam Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global RNA Drugs Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for RNA Drugs by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for RNA Drugs by Country/Region, 2019, 2023 & 2030
2.2 RNA Drugs Segment by Type
2.2.1 siRNA
2.2.2 ASO
2.2.3 miRNA
2.2.4 Nucleic Acid Aptamers
2.3 RNA Drugs Sales by Type
2.3.1 Global RNA Drugs Sales Market Share by Type (2019-2024)
2.3.2 Global RNA Drugs Revenue and Market Share by Type (2019-2024)
2.3.3 Global RNA Drugs Sale Price by Type (2019-2024)
2.4 RNA Drugs Segment by Application
2.4.1 Cancer
2.4.2 Diabetes
2.4.3 Tuberculosis
2.4.4 Cardiovascular Diseases
2.4.5 Others
2.5 RNA Drugs Sales by Application
2.5.1 Global RNA Drugs Sale Market Share by Application (2019-2024)
2.5.2 Global RNA Drugs Revenue and Market Share by Application (2019-2024)
2.5.3 Global RNA Drugs Sale Price by Application (2019-2024)
3 GLOBAL RNA DRUGS BY COMPANY
3.1 Global RNA Drugs Breakdown Data by Company
3.1.1 Global RNA Drugs Annual Sales by Company (2019-2024)
3.1.2 Global RNA Drugs Sales Market Share by Company (2019-2024)
3.2 Global RNA Drugs Annual Revenue by Company (2019-2024)
3.2.1 Global RNA Drugs Revenue by Company (2019-2024)
3.2.2 Global RNA Drugs Revenue Market Share by Company (2019-2024)
3.3 Global RNA Drugs Sale Price by Company
3.4 Key Manufacturers RNA Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers RNA Drugs Product Location Distribution
3.4.2 Players RNA Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR RNA DRUGS BY GEOGRAPHIC REGION
4.1 World Historic RNA Drugs Market Size by Geographic Region (2019-2024)
4.1.1 Global RNA Drugs Annual Sales by Geographic Region (2019-2024)
4.1.2 Global RNA Drugs Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic RNA Drugs Market Size by Country/Region (2019-2024)
4.2.1 Global RNA Drugs Annual Sales by Country/Region (2019-2024)
4.2.2 Global RNA Drugs Annual Revenue by Country/Region (2019-2024)
4.3 Americas RNA Drugs Sales Growth
4.4 APAC RNA Drugs Sales Growth
4.5 Europe RNA Drugs Sales Growth
4.6 Middle East & Africa RNA Drugs Sales Growth
5 AMERICAS
5.1 Americas RNA Drugs Sales by Country
5.1.1 Americas RNA Drugs Sales by Country (2019-2024)
5.1.2 Americas RNA Drugs Revenue by Country (2019-2024)
5.2 Americas RNA Drugs Sales by Type
5.3 Americas RNA Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC RNA Drugs Sales by Region
6.1.1 APAC RNA Drugs Sales by Region (2019-2024)
6.1.2 APAC RNA Drugs Revenue by Region (2019-2024)
6.2 APAC RNA Drugs Sales by Type
6.3 APAC RNA Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe RNA Drugs by Country
7.1.1 Europe RNA Drugs Sales by Country (2019-2024)
7.1.2 Europe RNA Drugs Revenue by Country (2019-2024)
7.2 Europe RNA Drugs Sales by Type
7.3 Europe RNA Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa RNA Drugs by Country
8.1.1 Middle East & Africa RNA Drugs Sales by Country (2019-2024)
8.1.2 Middle East & Africa RNA Drugs Revenue by Country (2019-2024)
8.2 Middle East & Africa RNA Drugs Sales by Type
8.3 Middle East & Africa RNA Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of RNA Drugs
10.3 Manufacturing Process Analysis of RNA Drugs
10.4 Industry Chain Structure of RNA Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 RNA Drugs Distributors
11.3 RNA Drugs Customer
12 WORLD FORECAST REVIEW FOR RNA DRUGS BY GEOGRAPHIC REGION
12.1 Global RNA Drugs Market Size Forecast by Region
12.1.1 Global RNA Drugs Forecast by Region (2025-2030)
12.1.2 Global RNA Drugs Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global RNA Drugs Forecast by Type
12.7 Global RNA Drugs Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer RNA Drugs Product Portfolios and Specifications
13.1.3 Pfizer RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Roche
13.2.1 Roche Company Information
13.2.2 Roche RNA Drugs Product Portfolios and Specifications
13.2.3 Roche RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Roche Main Business Overview
13.2.5 Roche Latest Developments
13.3 Sanofi-Aventis
13.3.1 Sanofi-Aventis Company Information
13.3.2 Sanofi-Aventis RNA Drugs Product Portfolios and Specifications
13.3.3 Sanofi-Aventis RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Sanofi-Aventis Main Business Overview
13.3.5 Sanofi-Aventis Latest Developments
13.4 Abbott Laboratories
13.4.1 Abbott Laboratories Company Information
13.4.2 Abbott Laboratories RNA Drugs Product Portfolios and Specifications
13.4.3 Abbott Laboratories RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Abbott Laboratories Main Business Overview
13.4.5 Abbott Laboratories Latest Developments
13.5 Arrowhead Pharmaceuticals
13.5.1 Arrowhead Pharmaceuticals Company Information
13.5.2 Arrowhead Pharmaceuticals RNA Drugs Product Portfolios and Specifications
13.5.3 Arrowhead Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Arrowhead Pharmaceuticals Main Business Overview
13.5.5 Arrowhead Pharmaceuticals Latest Developments
13.6 Benitec Biopharma
13.6.1 Benitec Biopharma Company Information
13.6.2 Benitec Biopharma RNA Drugs Product Portfolios and Specifications
13.6.3 Benitec Biopharma RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Benitec Biopharma Main Business Overview
13.6.5 Benitec Biopharma Latest Developments
13.7 Calimmune Inc
13.7.1 Calimmune Inc Company Information
13.7.2 Calimmune Inc RNA Drugs Product Portfolios and Specifications
13.7.3 Calimmune Inc RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Calimmune Inc Main Business Overview
13.7.5 Calimmune Inc Latest Developments
13.8 Dicerna
13.8.1 Dicerna Company Information
13.8.2 Dicerna RNA Drugs Product Portfolios and Specifications
13.8.3 Dicerna RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Dicerna Main Business Overview
13.8.5 Dicerna Latest Developments
13.9 Gradalis
13.9.1 Gradalis Company Information
13.9.2 Gradalis RNA Drugs Product Portfolios and Specifications
13.9.3 Gradalis RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Gradalis Main Business Overview
13.9.5 Gradalis Latest Developments
13.10 Quark
13.10.1 Quark Company Information
13.10.2 Quark RNA Drugs Product Portfolios and Specifications
13.10.3 Quark RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Quark Main Business Overview
13.10.5 Quark Latest Developments
13.11 RXi
13.11.1 RXi Company Information
13.11.2 RXi RNA Drugs Product Portfolios and Specifications
13.11.3 RXi RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 RXi Main Business Overview
13.11.5 RXi Latest Developments
13.12 Senesco
13.12.1 Senesco Company Information
13.12.2 Senesco RNA Drugs Product Portfolios and Specifications
13.12.3 Senesco RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Senesco Main Business Overview
13.12.5 Senesco Latest Developments
13.13 Silence Therapeutics
13.13.1 Silence Therapeutics Company Information
13.13.2 Silence Therapeutics RNA Drugs Product Portfolios and Specifications
13.13.3 Silence Therapeutics RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Silence Therapeutics Main Business Overview
13.13.5 Silence Therapeutics Latest Developments
13.14 Silenseed
13.14.1 Silenseed Company Information
13.14.2 Silenseed RNA Drugs Product Portfolios and Specifications
13.14.3 Silenseed RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 Silenseed Main Business Overview
13.14.5 Silenseed Latest Developments
13.15 Tekmira
13.15.1 Tekmira Company Information
13.15.2 Tekmira RNA Drugs Product Portfolios and Specifications
13.15.3 Tekmira RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Tekmira Main Business Overview
13.15.5 Tekmira Latest Developments
13.16 Alnylam Pharmaceuticals
13.16.1 Alnylam Pharmaceuticals Company Information
13.16.2 Alnylam Pharmaceuticals RNA Drugs Product Portfolios and Specifications
13.16.3 Alnylam Pharmaceuticals RNA Drugs Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 Alnylam Pharmaceuticals Main Business Overview
13.16.5 Alnylam Pharmaceuticals Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. RNA Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. RNA Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of siRNA
Table 4. Major Players of ASO
Table 5. Major Players of miRNA
Table 6. Major Players of Nucleic Acid Aptamers
Table 7. Global RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 8. Global RNA Drugs Sales Market Share by Type (2019-2024)
Table 9. Global RNA Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global RNA Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global RNA Drugs Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 13. Global RNA Drugs Sales Market Share by Application (2019-2024)
Table 14. Global RNA Drugs Revenue by Application (2019-2024)
Table 15. Global RNA Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global RNA Drugs Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global RNA Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global RNA Drugs Sales Market Share by Company (2019-2024)
Table 19. Global RNA Drugs Revenue by Company (2019-2024) ($ Millions)
Table 20. Global RNA Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global RNA Drugs Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers RNA Drugs Producing Area Distribution and Sales Area
Table 23. Players RNA Drugs Products Offered
Table 24. RNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global RNA Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global RNA Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global RNA Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global RNA Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global RNA Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global RNA Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global RNA Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global RNA Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas RNA Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas RNA Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas RNA Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas RNA Drugs Revenue Market Share by Country (2019-2024)
Table 39. Americas RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 40. Americas RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 41. APAC RNA Drugs Sales by Region (2019-2024) & (K Units)
Table 42. APAC RNA Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC RNA Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC RNA Drugs Revenue Market Share by Region (2019-2024)
Table 45. APAC RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 46. APAC RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 47. Europe RNA Drugs Sales by Country (2019-2024) & (K Units)
Table 48. Europe RNA Drugs Sales Market Share by Country (2019-2024)
Table 49. Europe RNA Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe RNA Drugs Revenue Market Share by Country (2019-2024)
Table 51. Europe RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 52. Europe RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa RNA Drugs Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa RNA Drugs Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa RNA Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa RNA Drugs Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of RNA Drugs
Table 60. Key Market Challenges & Risks of RNA Drugs
Table 61. Key Industry Trends of RNA Drugs
Table 62. RNA Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. RNA Drugs Distributors List
Table 65. RNA Drugs Customer List
Table 66. Global RNA Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global RNA Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas RNA Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas RNA Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC RNA Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC RNA Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe RNA Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe RNA Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa RNA Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa RNA Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global RNA Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global RNA Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global RNA Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global RNA Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Pfizer Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer RNA Drugs Product Portfolios and Specifications
Table 82. Pfizer RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Roche Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche RNA Drugs Product Portfolios and Specifications
Table 87. Roche RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. Sanofi-Aventis Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi-Aventis RNA Drugs Product Portfolios and Specifications
Table 92. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi-Aventis Main Business
Table 94. Sanofi-Aventis Latest Developments
Table 95. Abbott Laboratories Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Abbott Laboratories RNA Drugs Product Portfolios and Specifications
Table 97. Abbott Laboratories RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Abbott Laboratories Main Business
Table 99. Abbott Laboratories Latest Developments
Table 100. Arrowhead Pharmaceuticals Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Arrowhead Pharmaceuticals RNA Drugs Product Portfolios and Specifications
Table 102. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Arrowhead Pharmaceuticals Main Business
Table 104. Arrowhead Pharmaceuticals Latest Developments
Table 105. Benitec Biopharma Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Benitec Biopharma RNA Drugs Product Portfolios and Specifications
Table 107. Benitec Biopharma RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Benitec Biopharma Main Business
Table 109. Benitec Biopharma Latest Developments
Table 110. Calimmune Inc Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Calimmune Inc RNA Drugs Product Portfolios and Specifications
Table 112. Calimmune Inc RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Calimmune Inc Main Business
Table 114. Calimmune Inc Latest Developments
Table 115. Dicerna Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Dicerna RNA Drugs Product Portfolios and Specifications
Table 117. Dicerna RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Dicerna Main Business
Table 119. Dicerna Latest Developments
Table 120. Gradalis Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Gradalis RNA Drugs Product Portfolios and Specifications
Table 122. Gradalis RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Gradalis Main Business
Table 124. Gradalis Latest Developments
Table 125. Quark Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Quark RNA Drugs Product Portfolios and Specifications
Table 127. Quark RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Quark Main Business
Table 129. Quark Latest Developments
Table 130. RXi Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. RXi RNA Drugs Product Portfolios and Specifications
Table 132. RXi RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. RXi Main Business
Table 134. RXi Latest Developments
Table 135. Senesco Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Senesco RNA Drugs Product Portfolios and Specifications
Table 137. Senesco RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Senesco Main Business
Table 139. Senesco Latest Developments
Table 140. Silence Therapeutics Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Silence Therapeutics RNA Drugs Product Portfolios and Specifications
Table 142. Silence Therapeutics RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Silence Therapeutics Main Business
Table 144. Silence Therapeutics Latest Developments
Table 145. Silenseed Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Silenseed RNA Drugs Product Portfolios and Specifications
Table 147. Silenseed RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Silenseed Main Business
Table 149. Silenseed Latest Developments
Table 150. Tekmira Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Tekmira RNA Drugs Product Portfolios and Specifications
Table 152. Tekmira RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Tekmira Main Business
Table 154. Tekmira Latest Developments
Table 155. Alnylam Pharmaceuticals Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Alnylam Pharmaceuticals RNA Drugs Product Portfolios and Specifications
Table 157. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Alnylam Pharmaceuticals Main Business
Table 159. Alnylam Pharmaceuticals Latest Developments
Table 1. RNA Drugs Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. RNA Drugs Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of siRNA
Table 4. Major Players of ASO
Table 5. Major Players of miRNA
Table 6. Major Players of Nucleic Acid Aptamers
Table 7. Global RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 8. Global RNA Drugs Sales Market Share by Type (2019-2024)
Table 9. Global RNA Drugs Revenue by Type (2019-2024) & ($ million)
Table 10. Global RNA Drugs Revenue Market Share by Type (2019-2024)
Table 11. Global RNA Drugs Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 13. Global RNA Drugs Sales Market Share by Application (2019-2024)
Table 14. Global RNA Drugs Revenue by Application (2019-2024)
Table 15. Global RNA Drugs Revenue Market Share by Application (2019-2024)
Table 16. Global RNA Drugs Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global RNA Drugs Sales by Company (2019-2024) & (K Units)
Table 18. Global RNA Drugs Sales Market Share by Company (2019-2024)
Table 19. Global RNA Drugs Revenue by Company (2019-2024) ($ Millions)
Table 20. Global RNA Drugs Revenue Market Share by Company (2019-2024)
Table 21. Global RNA Drugs Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers RNA Drugs Producing Area Distribution and Sales Area
Table 23. Players RNA Drugs Products Offered
Table 24. RNA Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global RNA Drugs Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global RNA Drugs Sales Market Share Geographic Region (2019-2024)
Table 29. Global RNA Drugs Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global RNA Drugs Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global RNA Drugs Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global RNA Drugs Sales Market Share by Country/Region (2019-2024)
Table 33. Global RNA Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global RNA Drugs Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas RNA Drugs Sales by Country (2019-2024) & (K Units)
Table 36. Americas RNA Drugs Sales Market Share by Country (2019-2024)
Table 37. Americas RNA Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas RNA Drugs Revenue Market Share by Country (2019-2024)
Table 39. Americas RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 40. Americas RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 41. APAC RNA Drugs Sales by Region (2019-2024) & (K Units)
Table 42. APAC RNA Drugs Sales Market Share by Region (2019-2024)
Table 43. APAC RNA Drugs Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC RNA Drugs Revenue Market Share by Region (2019-2024)
Table 45. APAC RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 46. APAC RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 47. Europe RNA Drugs Sales by Country (2019-2024) & (K Units)
Table 48. Europe RNA Drugs Sales Market Share by Country (2019-2024)
Table 49. Europe RNA Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe RNA Drugs Revenue Market Share by Country (2019-2024)
Table 51. Europe RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 52. Europe RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa RNA Drugs Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa RNA Drugs Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa RNA Drugs Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa RNA Drugs Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa RNA Drugs Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa RNA Drugs Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of RNA Drugs
Table 60. Key Market Challenges & Risks of RNA Drugs
Table 61. Key Industry Trends of RNA Drugs
Table 62. RNA Drugs Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. RNA Drugs Distributors List
Table 65. RNA Drugs Customer List
Table 66. Global RNA Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global RNA Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas RNA Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas RNA Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC RNA Drugs Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC RNA Drugs Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe RNA Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe RNA Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa RNA Drugs Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa RNA Drugs Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global RNA Drugs Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global RNA Drugs Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global RNA Drugs Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global RNA Drugs Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. Pfizer Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 81. Pfizer RNA Drugs Product Portfolios and Specifications
Table 82. Pfizer RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Pfizer Main Business
Table 84. Pfizer Latest Developments
Table 85. Roche Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 86. Roche RNA Drugs Product Portfolios and Specifications
Table 87. Roche RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Roche Main Business
Table 89. Roche Latest Developments
Table 90. Sanofi-Aventis Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 91. Sanofi-Aventis RNA Drugs Product Portfolios and Specifications
Table 92. Sanofi-Aventis RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi-Aventis Main Business
Table 94. Sanofi-Aventis Latest Developments
Table 95. Abbott Laboratories Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 96. Abbott Laboratories RNA Drugs Product Portfolios and Specifications
Table 97. Abbott Laboratories RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Abbott Laboratories Main Business
Table 99. Abbott Laboratories Latest Developments
Table 100. Arrowhead Pharmaceuticals Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 101. Arrowhead Pharmaceuticals RNA Drugs Product Portfolios and Specifications
Table 102. Arrowhead Pharmaceuticals RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Arrowhead Pharmaceuticals Main Business
Table 104. Arrowhead Pharmaceuticals Latest Developments
Table 105. Benitec Biopharma Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 106. Benitec Biopharma RNA Drugs Product Portfolios and Specifications
Table 107. Benitec Biopharma RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Benitec Biopharma Main Business
Table 109. Benitec Biopharma Latest Developments
Table 110. Calimmune Inc Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 111. Calimmune Inc RNA Drugs Product Portfolios and Specifications
Table 112. Calimmune Inc RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Calimmune Inc Main Business
Table 114. Calimmune Inc Latest Developments
Table 115. Dicerna Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 116. Dicerna RNA Drugs Product Portfolios and Specifications
Table 117. Dicerna RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Dicerna Main Business
Table 119. Dicerna Latest Developments
Table 120. Gradalis Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 121. Gradalis RNA Drugs Product Portfolios and Specifications
Table 122. Gradalis RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Gradalis Main Business
Table 124. Gradalis Latest Developments
Table 125. Quark Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 126. Quark RNA Drugs Product Portfolios and Specifications
Table 127. Quark RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Quark Main Business
Table 129. Quark Latest Developments
Table 130. RXi Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 131. RXi RNA Drugs Product Portfolios and Specifications
Table 132. RXi RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. RXi Main Business
Table 134. RXi Latest Developments
Table 135. Senesco Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 136. Senesco RNA Drugs Product Portfolios and Specifications
Table 137. Senesco RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Senesco Main Business
Table 139. Senesco Latest Developments
Table 140. Silence Therapeutics Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 141. Silence Therapeutics RNA Drugs Product Portfolios and Specifications
Table 142. Silence Therapeutics RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Silence Therapeutics Main Business
Table 144. Silence Therapeutics Latest Developments
Table 145. Silenseed Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 146. Silenseed RNA Drugs Product Portfolios and Specifications
Table 147. Silenseed RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Silenseed Main Business
Table 149. Silenseed Latest Developments
Table 150. Tekmira Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 151. Tekmira RNA Drugs Product Portfolios and Specifications
Table 152. Tekmira RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Tekmira Main Business
Table 154. Tekmira Latest Developments
Table 155. Alnylam Pharmaceuticals Basic Information, RNA Drugs Manufacturing Base, Sales Area and Its Competitors
Table 156. Alnylam Pharmaceuticals RNA Drugs Product Portfolios and Specifications
Table 157. Alnylam Pharmaceuticals RNA Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. Alnylam Pharmaceuticals Main Business
Table 159. Alnylam Pharmaceuticals Latest Developments
LIST OF FIGURES
Figure 1. Picture of RNA Drugs
Figure 2. RNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global RNA Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global RNA Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. RNA Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of siRNA
Figure 10. Product Picture of ASO
Figure 11. Product Picture of miRNA
Figure 12. Product Picture of Nucleic Acid Aptamers
Figure 13. Global RNA Drugs Sales Market Share by Type in 2023
Figure 14. Global RNA Drugs Revenue Market Share by Type (2019-2024)
Figure 15. RNA Drugs Consumed in Cancer
Figure 16. Global RNA Drugs Market: Cancer (2019-2024) & (K Units)
Figure 17. RNA Drugs Consumed in Diabetes
Figure 18. Global RNA Drugs Market: Diabetes (2019-2024) & (K Units)
Figure 19. RNA Drugs Consumed in Tuberculosis
Figure 20. Global RNA Drugs Market: Tuberculosis (2019-2024) & (K Units)
Figure 21. RNA Drugs Consumed in Cardiovascular Diseases
Figure 22. Global RNA Drugs Market: Cardiovascular Diseases (2019-2024) & (K Units)
Figure 23. RNA Drugs Consumed in Others
Figure 24. Global RNA Drugs Market: Others (2019-2024) & (K Units)
Figure 25. Global RNA Drugs Sales Market Share by Application (2023)
Figure 26. Global RNA Drugs Revenue Market Share by Application in 2023
Figure 27. RNA Drugs Sales Market by Company in 2023 (K Units)
Figure 28. Global RNA Drugs Sales Market Share by Company in 2023
Figure 29. RNA Drugs Revenue Market by Company in 2023 ($ Million)
Figure 30. Global RNA Drugs Revenue Market Share by Company in 2023
Figure 31. Global RNA Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global RNA Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas RNA Drugs Sales 2019-2024 (K Units)
Figure 34. Americas RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 35. APAC RNA Drugs Sales 2019-2024 (K Units)
Figure 36. APAC RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Europe RNA Drugs Sales 2019-2024 (K Units)
Figure 38. Europe RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa RNA Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 41. Americas RNA Drugs Sales Market Share by Country in 2023
Figure 42. Americas RNA Drugs Revenue Market Share by Country in 2023
Figure 43. Americas RNA Drugs Sales Market Share by Type (2019-2024)
Figure 44. Americas RNA Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC RNA Drugs Sales Market Share by Region in 2023
Figure 50. APAC RNA Drugs Revenue Market Share by Regions in 2023
Figure 51. APAC RNA Drugs Sales Market Share by Type (2019-2024)
Figure 52. APAC RNA Drugs Sales Market Share by Application (2019-2024)
Figure 53. China RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 57. India RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe RNA Drugs Sales Market Share by Country in 2023
Figure 61. Europe RNA Drugs Revenue Market Share by Country in 2023
Figure 62. Europe RNA Drugs Sales Market Share by Type (2019-2024)
Figure 63. Europe RNA Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. France RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa RNA Drugs Sales Market Share by Country in 2023
Figure 70. Middle East & Africa RNA Drugs Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa RNA Drugs Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa RNA Drugs Sales Market Share by Application (2019-2024)
Figure 73. Egypt RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of RNA Drugs in 2023
Figure 79. Manufacturing Process Analysis of RNA Drugs
Figure 80. Industry Chain Structure of RNA Drugs
Figure 81. Channels of Distribution
Figure 82. Global RNA Drugs Sales Market Forecast by Region (2025-2030)
Figure 83. Global RNA Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global RNA Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global RNA Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global RNA Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global RNA Drugs Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of RNA Drugs
Figure 2. RNA Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global RNA Drugs Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global RNA Drugs Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. RNA Drugs Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of siRNA
Figure 10. Product Picture of ASO
Figure 11. Product Picture of miRNA
Figure 12. Product Picture of Nucleic Acid Aptamers
Figure 13. Global RNA Drugs Sales Market Share by Type in 2023
Figure 14. Global RNA Drugs Revenue Market Share by Type (2019-2024)
Figure 15. RNA Drugs Consumed in Cancer
Figure 16. Global RNA Drugs Market: Cancer (2019-2024) & (K Units)
Figure 17. RNA Drugs Consumed in Diabetes
Figure 18. Global RNA Drugs Market: Diabetes (2019-2024) & (K Units)
Figure 19. RNA Drugs Consumed in Tuberculosis
Figure 20. Global RNA Drugs Market: Tuberculosis (2019-2024) & (K Units)
Figure 21. RNA Drugs Consumed in Cardiovascular Diseases
Figure 22. Global RNA Drugs Market: Cardiovascular Diseases (2019-2024) & (K Units)
Figure 23. RNA Drugs Consumed in Others
Figure 24. Global RNA Drugs Market: Others (2019-2024) & (K Units)
Figure 25. Global RNA Drugs Sales Market Share by Application (2023)
Figure 26. Global RNA Drugs Revenue Market Share by Application in 2023
Figure 27. RNA Drugs Sales Market by Company in 2023 (K Units)
Figure 28. Global RNA Drugs Sales Market Share by Company in 2023
Figure 29. RNA Drugs Revenue Market by Company in 2023 ($ Million)
Figure 30. Global RNA Drugs Revenue Market Share by Company in 2023
Figure 31. Global RNA Drugs Sales Market Share by Geographic Region (2019-2024)
Figure 32. Global RNA Drugs Revenue Market Share by Geographic Region in 2023
Figure 33. Americas RNA Drugs Sales 2019-2024 (K Units)
Figure 34. Americas RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 35. APAC RNA Drugs Sales 2019-2024 (K Units)
Figure 36. APAC RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 37. Europe RNA Drugs Sales 2019-2024 (K Units)
Figure 38. Europe RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 39. Middle East & Africa RNA Drugs Sales 2019-2024 (K Units)
Figure 40. Middle East & Africa RNA Drugs Revenue 2019-2024 ($ Millions)
Figure 41. Americas RNA Drugs Sales Market Share by Country in 2023
Figure 42. Americas RNA Drugs Revenue Market Share by Country in 2023
Figure 43. Americas RNA Drugs Sales Market Share by Type (2019-2024)
Figure 44. Americas RNA Drugs Sales Market Share by Application (2019-2024)
Figure 45. United States RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 46. Canada RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 47. Mexico RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 48. Brazil RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 49. APAC RNA Drugs Sales Market Share by Region in 2023
Figure 50. APAC RNA Drugs Revenue Market Share by Regions in 2023
Figure 51. APAC RNA Drugs Sales Market Share by Type (2019-2024)
Figure 52. APAC RNA Drugs Sales Market Share by Application (2019-2024)
Figure 53. China RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 54. Japan RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 55. South Korea RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 56. Southeast Asia RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 57. India RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 58. Australia RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 59. China Taiwan RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 60. Europe RNA Drugs Sales Market Share by Country in 2023
Figure 61. Europe RNA Drugs Revenue Market Share by Country in 2023
Figure 62. Europe RNA Drugs Sales Market Share by Type (2019-2024)
Figure 63. Europe RNA Drugs Sales Market Share by Application (2019-2024)
Figure 64. Germany RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 65. France RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 66. UK RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 67. Italy RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 68. Russia RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 69. Middle East & Africa RNA Drugs Sales Market Share by Country in 2023
Figure 70. Middle East & Africa RNA Drugs Revenue Market Share by Country in 2023
Figure 71. Middle East & Africa RNA Drugs Sales Market Share by Type (2019-2024)
Figure 72. Middle East & Africa RNA Drugs Sales Market Share by Application (2019-2024)
Figure 73. Egypt RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 74. South Africa RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 75. Israel RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 76. Turkey RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 77. GCC Country RNA Drugs Revenue Growth 2019-2024 ($ Millions)
Figure 78. Manufacturing Cost Structure Analysis of RNA Drugs in 2023
Figure 79. Manufacturing Process Analysis of RNA Drugs
Figure 80. Industry Chain Structure of RNA Drugs
Figure 81. Channels of Distribution
Figure 82. Global RNA Drugs Sales Market Forecast by Region (2025-2030)
Figure 83. Global RNA Drugs Revenue Market Share Forecast by Region (2025-2030)
Figure 84. Global RNA Drugs Sales Market Share Forecast by Type (2025-2030)
Figure 85. Global RNA Drugs Revenue Market Share Forecast by Type (2025-2030)
Figure 86. Global RNA Drugs Sales Market Share Forecast by Application (2025-2030)
Figure 87. Global RNA Drugs Revenue Market Share Forecast by Application (2025-2030)
